These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21619671)

  • 41. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
    Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
    Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.
    Ma Y; Fei L; Zhang M; Zhang W; Liu X; Wang C; Luo Y; Zhang H; Han Y
    Oncotarget; 2017 Dec; 8(62):104813-104830. PubMed ID: 29285216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mcm7, a subunit of the presumptive MCM helicase, modulates its own expression in conjunction with Mcm1.
    Fitch MJ; Donato JJ; Tye BK
    J Biol Chem; 2003 Jul; 278(28):25408-16. PubMed ID: 12738768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.
    Hou J; Lambers M; den Hamer B; den Bakker MA; Hoogsteden HC; Grosveld F; Hegmans J; Aerts J; Philipsen S
    J Thorac Oncol; 2012 Jan; 7(1):105-14. PubMed ID: 22134068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of a novel component of the human minichromosome maintenance complex.
    Sakwe AM; Nguyen T; Athanasopoulos V; Shire K; Frappier L
    Mol Cell Biol; 2007 Apr; 27(8):3044-55. PubMed ID: 17296731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The MAT1 cyclin-dependent kinase-activating kinase (CAK) assembly/targeting factor interacts physically with the MCM7 DNA licensing factor.
    Wang Y; Xu F; Hall FL
    FEBS Lett; 2000 Oct; 484(1):17-21. PubMed ID: 11056214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclin A promotes S-phase entry via interaction with the replication licensing factor Mcm7.
    Chibazakura T; Kamachi K; Ohara M; Tane S; Yoshikawa H; Roberts JM
    Mol Cell Biol; 2011 Jan; 31(2):248-55. PubMed ID: 21078875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer.
    Zhong X; Guan X; Liu W; Zhang L
    Oncol Lett; 2014 Oct; 8(4):1470-1476. PubMed ID: 25202351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MCM7 amplification and overexpression are associated with prostate cancer progression.
    Ren B; Yu G; Tseng GC; Cieply K; Gavel T; Nelson J; Michalopoulos G; Yu YP; Luo JH
    Oncogene; 2006 Feb; 25(7):1090-8. PubMed ID: 16247466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.
    Yang J; Li Y; Khoury T; Alrawi S; Goodrich DW; Tan D
    Ann Clin Lab Sci; 2008; 38(2):105-12. PubMed ID: 18469354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
    Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
    Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.
    Saydam O; Senol O; Schaaij-Visser TB; Pham TV; Piersma SR; Stemmer-Rachamimov AO; Wurdinger T; Peerdeman SM; Jimenez CR
    J Proteome Res; 2010 Jan; 9(1):485-94. PubMed ID: 19877719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
    Fristrup N; Birkenkamp-Demtröder K; Reinert T; Sanchez-Carbayo M; Segersten U; Malmström PU; Palou J; Alvarez-Múgica M; Pan CC; Ulhøi BP; Borre M; Ørntoft TF; Dyrskjøt L
    Am J Pathol; 2013 Feb; 182(2):339-49. PubMed ID: 23201130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance.
    Nishihara K; Shomori K; Tamura T; Fujioka S; Ogawa T; Ito H
    Oncol Rep; 2009 May; 21(5):1189-95. PubMed ID: 19360293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
    Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
    PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Kiyono T; Fleck E; Van Herle A; Graf K; Law RE
    Eur J Pharmacol; 2003 Feb; 462(1-3):15-23. PubMed ID: 12591091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.